| Company | Reagent | Link to information | Remarks |
|---|---|---|---|
| Chromogenix | Coamatic Antithrombin | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti Xa | |
| Chromogenix | Coamatic LR Antithrombin | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa | |
| Helena Biosciences | Antithrombin Xa | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti Xa | |
| Hyphen BioMed | Biophen Antithrombin | Hyphen Biophen Antithrombin | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin, heparin Cofactor II, alpha-2-macroglobulin or alpha1-Antitrypsin.No significant interference for haemoglobin < 2.5 mg/ml, and bilirubin < 0.1 mg/ml |
| Hyphen BioMed | Biophen AT anti-(h)-Xa LRT | Hyphen Biophen AT anti-(h)-Xa LRT | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin, heparin Cofactor II, alpha-2-macroglobulin or alpha1-Antitrypsin.No significant interference for haemoglobin < 2.5 mg/ml, and bilirubin < 0.1 mg/ml |
| Hyphen BioMed | Biophen AT (anti-lla) | Hyphen Biophen AT (anti-lla) | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti IIa Interferences: No interference of heparin (UFH, LMWH) at usual therapeutic doses |
| Hyphen BioMed | Biophen AT (LRT) | Hyphen Biophen AT (LRT) | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin, heparin Cofactor II, alpha-2-macroglobulin or alpha1-Antitrypsin.No significant interference for haemoglobin < 2.5 mg/ml, and bilirubin < 0.1 mg/ml |
| Nordic Biomarker | MRX Antithrombin | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa | |
| Renam | Reachrom-ATIII | Method: Chromogenic | |
| Renam | Reaclot-ATIII | Method: Clotting | |
| Roche | AT | Roche AT | Reagent: Liquid Method: Chromogenic Assay principle: anti IIa |
| Siemens Healthineers | Berichrom Antithrombin III | Siemens Berichrom Anthitrombin III | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti Xa Inteferences: Therapeutic doses of hirudin or other direct thrombin inhibitors will cause erroneously |
| Siemens Healthineers | Innovance Antithrombin | Siemens Innovance Antithrombin | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin < 2 U/ml, heparin cofactor II < 400 mg/L, hirudin < 5 mg/L, therapeutic doses of oral direct factor Xa inhibitors may cause erroneously increased |
| Stago | STA-Stachrom AT III | Stago STA-Stachrom AT III | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti IIa Interferences: No interferences of therapeutic doses of heparin, hemoglobin < 7 g/l, bilirubin < 200 mg/l, |
| Stago, Tcoag | TriniCHROM Antithrombin lla | Stago TriniCHROM Antitrombin IIa | Method: Chromogenic Assay principle: Anti IIa Interferences: Interference of heparin cofactor |
| Stago, Tcoag | TriniCHROM Antithrombin Xa | Stago TriniCHROM Antitrombin Xa | Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin cofactor II |
| Technoclone | Technochrom ATIII kit | Technoclone Technochrom ATIII kit | Method: Chromogenic Assay principle: Anti IIa |
| Technoclone | Technochrom ATIII manual method kit | Technoclone Technochrom ATIII manual method kit | Method: Chromogenic Assay principle: Anti IIa |
| Werfen | HemosIL Antithrombin | Werfen HemosIL Antithrombin | Reagent: Lyophilized Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of (UF heparin or LMW |
| Werfen | HemosIL liquid Antithrombin | Werfen HemosIL liquid Antithrombin | Reagent: Liquid Method: Chromogenic Assay principle: Anti Xa Interferences: No interference of heparin (UF heparin or LMW |
